ANDG is a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock has positive momentum, strong recent revenue growth, improving gross margin, and supportive analyst sentiment with multiple price target raises. While net income remains negative, the overall operating trend is improving, and the current setup still looks attractive for a long-term entry. Given the investor is impatient and does not want to wait for a better pullback, this is a reasonable buy now rather than a hold.
ANDG closed at 35.38 after a 4.30% gain, showing near-term strength. The moving averages are bullish with SMA_5 > SMA_20 > SMA_200, which supports an uptrend. RSI_6 at 60.233 is neutral to mildly bullish, suggesting the stock is not overextended. MACD histogram is slightly negative and expanding lower, so momentum is not fully confirmed yet. Key levels to watch are pivot 34.888, support at 33.523, and resistance at 36.254. Overall, the trend is positive and the stock is trading above its pivot, which supports a constructive outlook.
["Q4 2025 revenue increased 19.62% YoY", "Gross margin improved significantly to 23.52%", "UBS and Baird raised price targets and maintained positive ratings", "New board appointment of Sue Decker adds strategic and governance strength", "Similar candlestick pattern analysis suggests near-term upside potential"]
["Net income remains negative at -68.0 million", "EPS is still negative", "MACD histogram is below zero and weakening", "Hedge funds and insiders show no significant buying trend", "No valuation data available to confirm discount or premium"]
In Q4 2025, Andersen Group posted revenue of 170.3 million, up 19.62% year over year, showing strong top-line growth. Gross margin rose to 23.52%, indicating better operating efficiency. However, the company still reported a net loss of 68.0 million and negative EPS of -3.87, even though both improved sharply from the prior year. The latest quarter shows solid growth trends but profitability is not yet established.
Wall Street sentiment is mixed but leaning positive. UBS raised its price target twice, most recently to $34 from $32, and kept a Buy rating. Baird was more bullish, raising its target to $42 and maintaining an Outperform rating after strong Q4 results. Morgan Stanley was more cautious with an Equal Weight rating and a $24 target, but it still acknowledged strong post-IPO results with revenue and EBITDA ahead of expectations. Overall, analysts see improving fundamentals and favorable upside, with the main con being that not all firms are fully bullish yet.